CLONING EXPRESSION AND TRANSPORT STUDIES OF SENDAI VIRUS
Project Number1R15AI031191-01
Contact PI/Project LeaderMCQUEEN, NANCY LUGENE
Awardee OrganizationCALIFORNIA STATE UNIVERSITY LOS ANGELES
Description
Abstract Text
Polarized epithelial cells are important in regulating the environment
between external and internal compartments in an organism. Many malignant
and nonmalignant diseases are characterized by changes in cell polarity.
It is not known whether these are a cause or effect of the specific
disease, but an understanding of the biogenesis, transport, assembly and
maintenance of polarized cells may lead to important insights on the
mechanisms and/or treatments of these diseases. Studies providing the most
insight into these processes have utilized, as models, the infection of
polarized monolayers of MDCK cells by enveloped RNA viruses. Such studies
have shown that certain viruses such as influenza virus and Sendai virus
bud only from the apical domain, whereas other viruses such as vesicular
stomatitis virus bud exclusively from the basolateral domain. This project
proposes to clone, express and follow the transport in eukaryotic cells of
proteins encoded in the viral genome of one of these viruses, Sendai virus,
and its variant, Fl-R. The two viruses differ in their site of budding
in polarized cells. In other viral systems, the envelope glycoproteins,
when expressed without any other viral genes, have been shown to localize
in the same domain from which the virus ultimately buds. This indicates
that their polypeptide backbones contain a signal for polarized transport.
We will first test to see if this holds true for the Sendai viral proteins.
Assuming it does, we hope to utilize their difference in transport site to
identify sorting signals in the membrane proteins. The differences in the
RNA and protein sequences of the two viruses have recently been published.
Utilizing this information we will use site specific mutagenesis to
systematically change the variant sequences back to wild-type. Each
possible combination of the wild-type and variant sequence will be
expressed and the transport followed. Thus, we should be able to identify
the mutation(s) responsible for the difference in polarized expression of
the proteins.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
biological transportgene deletion mutationgene expressionglycoproteinsintracellular transportmembrane proteinsmolecular cloningmutantnonhistone nucleoproteinparainfluenza virus type 1protein biosynthesisprotein sequenceprotein signal sequenceprotein transportvirus envelopevirus geneticsvirus protein
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
066697590
UEI
C1ABLRAQTB48
Project Start Date
01-May-1991
Project End Date
30-April-1994
Budget Start Date
01-May-1991
Budget End Date
30-April-1994
Project Funding Information for 1991
Total Funding
$101,310
Direct Costs
$74,967
Indirect Costs
$26,343
Year
Funding IC
FY Total Cost by IC
1991
National Institute of Allergy and Infectious Diseases
$101,310
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R15AI031191-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R15AI031191-01
Patents
No Patents information available for 1R15AI031191-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R15AI031191-01
Clinical Studies
No Clinical Studies information available for 1R15AI031191-01
News and More
Related News Releases
No news release information available for 1R15AI031191-01
History
No Historical information available for 1R15AI031191-01
Similar Projects
No Similar Projects information available for 1R15AI031191-01